Article
Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance
14 Oct 2022
Abstract excerpt
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm initiated by the presence of the fusion gene BCR::ABL1. The development of tyrosine kinase inhibitors (TKIs) highly specific to p210BCR-ABL1, the constitutively active tyrosine kinase encoded by BCR::ABL1, has greatly improved the prognosis for CML patients. Now, the survival rate of CML nearly parallels that of age matched controls. However, therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
